2017
DOI: 10.1002/dc.23843
|View full text |Cite
|
Sign up to set email alerts
|

Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3‐year follow‐up in an academic institute

Abstract: HR-HPV testing plays an important role in cervical cancer screening by identifying HSIL in patients with ASC-US, LSIL, and NILM. Co-testing is an optimal method to identifying the patients with higher risk for developing cervical abnormalities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 50 publications
0
5
0
1
Order By: Relevance
“…Epidemiological studies have demonstrated that HPV, particularly HR-HPV type, is the major causative factor in the development of cervical cancer (9). However, HPV prevalence and type distribution vary depending on geographical region within countries (10).…”
Section: Discussionmentioning
confidence: 99%
“…Epidemiological studies have demonstrated that HPV, particularly HR-HPV type, is the major causative factor in the development of cervical cancer (9). However, HPV prevalence and type distribution vary depending on geographical region within countries (10).…”
Section: Discussionmentioning
confidence: 99%
“…Patients diagnosed with cervical cancer often show no obvious signs or symptoms at early stages, which fact can lead to misdiagnosis. The incidence of cervical cancer worldwide varies significantly due to advancements in research and precautionary measures taken by developed countries [5]. Incidence decline can be attributed to regular application of Pap tests, which can reveal CINs and carcinoma in situ before they develop into cervical cancer, and vaccination [6].…”
Section: Introductionmentioning
confidence: 99%
“…Cervical cytologic screening has generally been used to detect cervical cancer and premalignant lesions over the past decade, and early diagnosis and appropriate treatment reduce the risk of cancer-related death. 4 …”
Section: Introductionmentioning
confidence: 99%